The funding could create a regulatory approval pathway for future applications of clinical-grade artificial intelligence.
ARPA-H to invest $62M to build agentic AI agent for heart care
ARPA-H to invest $62M to build agentic AI agent for heart care is a pharma and life sciences industry update from Healthcare Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: Healthcare Dive